Literature DB >> 20971060

Trichosanthin affects HSV-1 replication in Hep-2 cells.

Dong-Xu He1, Siu-Cheung Tam.   

Abstract

Trichosanthin (TCS) is a type I ribosome-inactivating protein that inhibits the replication of both human immunodeficiency virus type 1 (HIV-1) and herpes simplex virus type 1 (HSV-1). The mechanism of inhibition is not clear. This investigation explored the effects of TCS on the stages of HSV-1 infection in Hep-2 cells, from attachment to release. We demonstrated that TCS reduced HSV-1 antigen and DNA content and interfered with viral replication as early as 3-15 h after infection. TCS had no effect on HSV-1 attachment, penetration or immediate-early gene expression. However, the expression of early and late genes and virion release were diminished. In summary, this study demonstrates that TCS primarily affects HSV-1 replication in Hep-2 cells during the early to late infection period.
Copyright © 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20971060     DOI: 10.1016/j.bbrc.2010.10.080

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  5 in total

1.  Chromium(III) and iron(III) inhibits replication of DNA and RNA viruses.

Authors:  Sylwia Terpiłowska; Andrzej Krzysztof Siwicki
Journal:  Biometals       Date:  2017-06-13       Impact factor: 2.949

Review 2.  Structural and Functional Investigation and Pharmacological Mechanism of Trichosanthin, a Type 1 Ribosome-Inactivating Protein.

Authors:  Wei-Wei Shi; Kam-Bo Wong; Pang-Chui Shaw
Journal:  Toxins (Basel)       Date:  2018-08-20       Impact factor: 4.546

Review 3.  Antiviral Activity of Ribosome-Inactivating Proteins.

Authors:  Lucía Citores; Rosario Iglesias; José M Ferreras
Journal:  Toxins (Basel)       Date:  2021-01-22       Impact factor: 4.546

4.  Trichosanthin inhibits breast cancer cell proliferation in both cell lines and nude mice by promotion of apoptosis.

Authors:  Evandro Fei Fang; Chris Zhi Yi Zhang; Lin Zhang; Jack Ho Wong; Yau Sang Chan; Wen Liang Pan; Xiu Li Dan; Cui Ming Yin; Chi Hin Cho; Tzi Bun Ng
Journal:  PLoS One       Date:  2012-09-05       Impact factor: 3.240

5.  TRPC1 participates in the HSV-1 infection process by facilitating viral entry.

Authors:  DongXu He; AiQin Mao; YouRan Li; SiuCheung Tam; YongTang Zheng; XiaoQiang Yao; Lutz Birnbaumer; Indu S Ambudkar; Xin Ma
Journal:  Sci Adv       Date:  2020-03-18       Impact factor: 14.136

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.